Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Langerhans cells are crucial for skin immunity and allergic reactions.

Blocking interferon-gamma might help treat various autoimmune diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.